TPBG
MRNA icon

Turning Point Benefit Group’s Moderna MRNA Stock Holding History

Turning Point Benefit Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35
Closed -$1.03K – 527
2025
Q4 		$1.03K Buy
35
+34
+3,400% +$924 ﹤0.01% 559
2025
Q3 		$27 Buy
+1
New +$28 ﹤0.01% 753

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Turning Point Benefit Group's MRNA Position: Q1 2026 in Review

Turning Point Benefit Group sold out of Moderna (MRNA) in Q1 2026, closing a stake of 35 shares — an estimated $1.03K sold.

Turning Point Benefit Group first reported a position in MRNA in Q3 2025 and held it in 2 quarters. The position peaked at $1.03K in Q4 2025. 726 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Turning Point Benefit Group reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Turning Point Benefit Group sold 35 Moderna shares in Q1 2026, an estimated $1.03K.
  • Turning Point Benefit Group first reported a position in Moderna in Q3 2025 and held it in 2 quarters.
  • Turning Point Benefit Group's Moderna position peaked at $1.03K in Q4 2025.
  • 726 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.